Genmab A/S ( GMAB) - Key Metrics
GMAB Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.88 | $0.49 | $0.08 | $0.08 |
| 2026Q1 | $1.47 | $0.09 | $0 | $0 |
| 2025Q4 | $1.71 | $0.05 | $0.49 | $0.47 |
| 2025Q3 | $1.66 | $0.65 | $0.87 | $0.87 |
| 2025Q2 | $1.50 | $0.54 | $0.10 | $0.08 |
GMAB Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 14.02 |
| 2026Q1 | 0% | 77.10 |
| 2025Q4 | 0% | 154 |
| 2025Q3 | 0% | 11.80 |
| 2025Q2 | 0% | 9.49 |
GMAB Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 0.28% | 0% |
| 2026Q1 | -0.01% | 0% |
| 2025Q4 | 1.51% | 0% |
| 2025Q3 | 2.83% | 0% |
| 2025Q2 | 0.41% | 0% |
GMAB
Price: $36.79
52 week price:
Earnings Per Share: 1.29 USD
P/E Ratio: 24.36
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Denmark
Volume: 221594
Market Capitalization: 21.3 billion